December 9, 2019 by Tom Martin
food as medicine, Inmar, Tom Martin
November 18, 2019, Opinion

While it may be difficult to imagine, shoppers are becoming even more health- and nutrition-conscious than they already are. And, as their collective commitment to better nutrition intensifies, shoppers are going to expect even more from retailers and brands when it comes to assistance with, and information about, healthier eating. With shoppers’ heightened focus on
December 9, 2019 by Jeffrey Woldt
Amazon/PillPack, CVS Health, Walmart Health
December 9, 2019, News

Long anticipated and much discussed, a new era in community pharmacy is finally unfolding. Spearheaded by a small group of visionaries, traditional brick-and-mortar pharmacies have started to evolve into community-based health care centers, even as e-commerce companies try to shift the profession’s primary point of contact with patients from the physical to the digital realm.
December 9, 2019 by Dan Stanek
Dan Stanek, health care, retailers
December 9, 2019, Opinion

There’s never been a better time for health care leaders to think outside the [big] box. According to consulting firm McKinsey, health care providers are experiencing a confluence of forces driving a significant move from inpatient care to: • Distributed settings of care. • Locations that answer consumers’ growing demand for convenience. • Lower-cost, less
December 9, 2019 by Chain Drug Review
Medicare, Walgreens
December 9, 2019, News

DEERFIELD, Ill. — Walgreens continues to broaden its health care offerings, opening physician-staffed clinics and announcing the debut of in-store Medicare services centers. In Houston, the retailer unveiled the first of five “Village Medical at Walgreens” clinics. In partnership with Chicago-based VillageMD, Walgreens will premiere the other four clinics over the next two months. The
December 9, 2019 by Larry King
Larry King, new NCPDP SCRIPT v2017071, Surescripts
December 9, 2019, Pharmacy

Years ago, when I was a retail pharmacist at a local pharmacy in Brooklyn, it wasn’t uncommon for customers to come in to refill a medication that was originally prescribed to them after being discharged from one of the many area hospitals. It was even more difficult back then to track down the appropriate doctor
December 9, 2019 by Chain Drug Review
diabetes care, Elin Ostman, Good Idea Water
December 9, 2019, Pharmacy

LARKSPUR, Calif. — If a diabetes educator could give one single piece of advice, it would probably be to replace sugary sodas and energy drinks with water. Good Idea could be described as an upgraded version of water that makes a switch both easier and more efficient. Good Idea is a carbonated, naturally flavored water
December 9, 2019 by Mark Mechelse
GMDC, Mark Mechelse, self-care
December 9, 2019, Opinion

The retail industry has experienced extraordinary disruption over the past decade, and it continues to shift today. But retail itself has also begun to disrupt a behemoth of an industry: health care. The quickly growing self-care movement — which inspires consumers to embrace proactive life choices through investment in accessible wellness and better-for-you methods —
December 9, 2019 by Chain Drug Review
Amazon, PillPack
December 9, 2019, News

SEATTLE — According to published reports from CNBC, PillPack has updated its logo and other paperwork to include a new “Amazon Pharmacy” brand, and its chief executive officer, TJ Parker, has been promoted to vice president within Amazon. Specifically, the group’s branding has changed from “PillPack, an Amazon company” to “PillPack by Amazon Pharmacy.” It’s
December 9, 2019 by David Pinto
Walmart, Wegmans
December 9, 2019, Opinion

Has anyone in the chain drug retailing community visited the new Wegmans in Brooklyn? Has anyone been to Dallas, Ga., to experience the bold and exciting new Walmart experiment in affordable and accessible health care? Has chain drug retailing become so complacent and sure of itself that the newest and most stunning mass retailing innovations
December 9, 2019 by Bill Oldham and Robin Robinson
Bill Oldham, diabetes wound care, Robin Robinson, Thought Leadership and Innovation Foundation
December 9, 2019, Pharmacy

Chronic wounds associated with burns and diabetes are a prevalent and costly problem in the United States, prompting demand for treatments that can heal wounds and prevent serious complications, such as infection and amputation. Recent advances in wound healing have the potential to regenerate rather than repair tissue, including customizable nanofiber matrices incorporating novel materials,
December 6, 2019 by Brian Bossetta
CVS, SheaMoisture, Ulta
November 18, 2019

NEW YORK — America is becoming more and more diverse, and as that diversity spreads it will have a major influence on retailers as the impact of the multicultural shopper becomes more significant. The U.S. multicultural population is projected to grow by 98 million in the coming decades, according to Acosta, a sales and marketing
November 18, 2019 by Crystal Lennartz
Crystal Lennartz, McKesson, pharmacy
November 18, 2019, Pharmacy

Value-based care models have been used in health care for years, trying to strike a balance between coverage, cost and quality. While value-based care is relatively new to pharmacy, we are beginning to see a spectrum of new payment methods ranging from traditional fee for service to shared savings and risk-bearing models based on patient
November 18, 2019 by Scott Howell
diabetes, Echosens, liver diseases, Scott Howell
November 18, 2019, Pharmacy

A race is under way among pharmaceutical companies to develop drugs that treat a spectrum of liver diseases, including nonalcoholic fatty liver disease (NAFLD), an asymptomatic condition characterized by elevated levels of fat in the liver, and its more severe form, nonalcoholic steatohepatitis (NASH). The main risk factors for fatty liver disease include a sedentary
November 18, 2019 by Jeffrey Woldt
DIR fee reform, Doug Hoey, NCPA
November 18, 2019, Opinion

This space in the last issue of Chain Drug Review was devoted to the alarming results of a survey conducted by the National Community Pharmacists Association that show 58% of independent drug store owners think it is either somewhat or very likely that continued downward pressure on pharmacy reimbursements, particularly DIR fees, will force them